Abstract:Bacterial bloodstream infections (BSI) are a common threat among patients with haematological malignancies (HM) and hematopoietic stem cell transplant recipients (HSCT). The purpose of this research was to describe clinical and microbiological aspects of BSI caused by carbapenem-resistant Klebsiella pneumoniae (CRKp) and assess risk factors associated with 30-day mortality in a 10-year cohort of haematological patients. A total of 65 CRKp-BSI episodes occurring in HM patients and HSCT recipients and CRKp-BSI between January 2010 and December 2019 were retrospectively studied. Acute leukemias were the most frequently observed underlying disease (87.7%) and 18 patients (27.7%) received HSCT. Mucosal barrier injury in the gastrointestinal tract was the primary cause of bacteremia (86.1%). Also, 14 individuals (21.6%) had an Invasive Fungal Disease (IFD) throughout the episode. Regarding treatment, in 31 patients (47.7%) empirical therapy was deemed appropriate, whereas 33 (50.8%) patients received a combination therapy. Microbiological data revealed that the majority of isolates (53–58%) had the Polymyxin B co-resistance phenotype, while amikacin resistance was less common (16 samples, or 24.7%). The mortality rates at 14 and 30 days were 32.3% and 36.9%, respectively. In a multivariate Cox regression analysis, prompt appropriate antibiotic administration within three days was associated with a better outcome (Adjusted Hazard Ratio [aHR]: 0.33; 95% Confidence Interval [CI]: 0.14–0.76; p = 0.01), whereas hypotension at presentation (aHR: 3.88; 95% CI: 1.40–10.74; p = 0.01) and concurrent IFD (aHR: 2.97; 95% CI: 1.20–7.37; p = 0.02) were independently associated with death within 30 days. Additionally, a favorable correlation between combination therapy and overall survival was found (aHR: 0.18; 95%CI: 0.06–0.56; p = 0.002). In conclusion, 30-day mortality CRKp-BSI was elevated and most of the isolates were polymyxin B resistant. Early appropriate antimicrobial treatment and the use of combination therapy were linked to a better outcome.

Necrotizing Periodontal Diseases As A Poor Prognostic Factor In Patients With Hematological Malignancies: A Case Series

[Following-Up of Nosocomial Lower Respiratory Infection in Patients with Hematological Malignancy after Chemotherapy].

Severe Necrotizing Periodontitis in an HIV-Infected Patient: Case Report and Non-Surgical Treatment

Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults

Case Report: Mucormycosis Oral Lesion In A Patient With Hematological Malignancy.

Systemic management and periodontal treatment of HIV-necrotizing periodontitis: A case report

Interactions between Periodontitis and Hematologic Diseases

Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma

Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in haematological malignances and hematopoietic stem cell transplantation: Clinical impact of combination therapy in a 10-year Brazilian cohort

Significance of Dental Intervention in Onco-Hematological Disorders: A Case Report of Gingival Leukemic Infiltration

Specialized Care In Oral Medicine In The Prognosis Of Patients Referred To An Oncological Center: Retrospective Cohort.

The Role Of The Dentist In The Hospital In Diagnosis And Management Of Hematologically Based Disorders.

Non-inflammatory destructive periodontal disease: a clinical, microbiological, immunological and genetic investigation

The Reversed Halo Sign: Pathognomonic Pattern of Pulmonary Mucormycosis in Leukemic Patients With Neutropenia?

Oral Infection By Capnocytophaga Sputigena In A Patient Submitted To Hematopoietic Stem Cell Transplantation.

Hematopoietic and Lymphatic Cancers in Patients with Periodontitis: a Systematic Review and Meta-Analysis

Antimicrobial photodynamic therapy as treatment of infected oral ulcers in patients undergoing hematopoietic stem cell transplantation: Report of two cases

Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients

Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock

Importance Of The Dental Surgeon In Onco-Hematological Diseases: Report Of Gingival Leukemic Infiltration.

Oral malignant and potentially malignant lesions after allogenic hematopoietic cell transplantation: a 10-year follow-up study